NCT02201186

Brief Summary

Patients with a bowel condition called ulcerative colitis have bowel surgery in which a portion of their bowel is removed and the reconnected at the small bowel to the anus. Sometimes, after the surgery, this connection part, the pouch, would be inflamed in a condition called Acute Pouchitis. Physicians usually treat them by prescribing antibiotics; however, some patients do not respond and need additional surgery. In this study, we will test an alternative treatment for this complication by performing manuka honey enemas twice a day for 30 days. This is a pilot study and ten patients will undergo enema treatment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for phase_2

Timeline
Completed

Started Oct 2014

Shorter than P25 for phase_2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 19, 2014

Completed
6 days until next milestone

First Posted

Study publicly available on registry

July 25, 2014

Completed
2 months until next milestone

Study Start

First participant enrolled

October 1, 2014

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2015

Completed
Last Updated

April 26, 2017

Status Verified

April 1, 2017

Enrollment Period

1.1 years

First QC Date

July 19, 2014

Last Update Submit

April 24, 2017

Conditions

Keywords

honey enema for pouchitis

Outcome Measures

Primary Outcomes (1)

  • PDAI score

    PDAI score is a criterion for defining pouchitis. A PDAI score will be calculated from a proctoscopy assessment before treatment. Within two weeks after the treatment, another proctoscopy will be performed to determine the post-treatment PDAI score to see if there is a decrease in PDAI score for the study patients.

    within 2 weeks after the 30-day treatment

Secondary Outcomes (1)

  • Composite complications

    throughout the 30-day honey enema treatment and within two weeks of the treatment completion date

Study Arms (1)

manuka honey enema treatment

EXPERIMENTAL

Study patients diagnosed with acute pouchitis after bowel surgery for ulcerative colitis will perform manuka honey enemas twice a day for 30 days.

Other: Manuka honey enema

Interventions

Study patients diagnosed with acute pouchitis will perform manuka honey enemas twice a day for 30 days.

manuka honey enema treatment

Eligibility Criteria

Age19 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • have given written informed consent
  • have been diagnosed with ulcerative colitis
  • have had total colectomy and ileal pouch anal anastomosis before
  • have presented with signs and symptoms of pouchitis within the last two months of signing the informed consent
  • PDAI of greater than or equal to 7

You may not qualify if:

  • patients who are unable to perform enema by themselves
  • patients with an allergy to honey

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Saint Paul's Hospital

Vancouver, British Columbia, V6Z 1Y6, Canada

Location

Related Publications (9)

  • Sandborn WJ, Tremaine WJ, Batts KP, Pemberton JH, Phillips SF. Pouchitis after ileal pouch-anal anastomosis: a Pouchitis Disease Activity Index. Mayo Clin Proc. 1994 May;69(5):409-15. doi: 10.1016/s0025-6196(12)61634-6.

    PMID: 8170189BACKGROUND
  • Shen B, Achkar JP, Connor JT, Ormsby AH, Remzi FH, Bevins CL, Brzezinski A, Bambrick ML, Fazio VW, Lashner BA. Modified pouchitis disease activity index: a simplified approach to the diagnosis of pouchitis. Dis Colon Rectum. 2003 Jun;46(6):748-53. doi: 10.1007/s10350-004-6652-8.

    PMID: 12794576BACKGROUND
  • Kafadar I, Moustafa F, Yalcin K, Klc BA. A rare adverse effect of metronidazole: nervous system symptoms. Pediatr Emerg Care. 2013 Jun;29(6):751-2. doi: 10.1097/PEC.0b013e318294f389.

    PMID: 23736071BACKGROUND
  • Makhdoom A, Khan MS, Lagahari MA, Rahopoto MQ, Tahir SM, Siddiqui KA. Management of diabetic foot by natural honey. J Ayub Med Coll Abbottabad. 2009 Jan-Mar;21(1):103-5.

    PMID: 20364754BACKGROUND
  • Kilicoglu B, Gencay C, Kismet K, Serin Kilicoglu S, Erguder I, Erel S, Sunay AE, Erdemli E, Durak I, Akkus MA. The ultrastructural research of liver in experimental obstructive jaundice and effect of honey. Am J Surg. 2008 Feb;195(2):249-56. doi: 10.1016/j.amjsurg.2007.04.011.

    PMID: 18083132BACKGROUND
  • Cernak M, Majtanova N, Cernak A, Majtan J. Honey prophylaxis reduces the risk of endophthalmitis during perioperative period of eye surgery. Phytother Res. 2012 Apr;26(4):613-6. doi: 10.1002/ptr.3606. Epub 2011 Oct 6.

    PMID: 22508360BACKGROUND
  • Hussein SZ, Mohd Yusoff K, Makpol S, Mohd Yusof YA. Gelam Honey Inhibits the Production of Proinflammatory, Mediators NO, PGE(2), TNF-alpha, and IL-6 in Carrageenan-Induced Acute Paw Edema in Rats. Evid Based Complement Alternat Med. 2012;2012:109636. doi: 10.1155/2012/109636. Epub 2012 Jul 1.

    PMID: 22919407BACKGROUND
  • Medhi B, Prakash A, Avti PK, Saikia UN, Pandhi P, Khanduja KL. Effect of Manuka honey and sulfasalazine in combination to promote antioxidant defense system in experimentally induced ulcerative colitis model in rats. Indian J Exp Biol. 2008 Aug;46(8):583-90.

    PMID: 18814487BACKGROUND
  • Viuda-Martos M, Ruiz-Navajas Y, Fernandez-Lopez J, Perez-Alvarez JA. Functional properties of honey, propolis, and royal jelly. J Food Sci. 2008 Nov;73(9):R117-24. doi: 10.1111/j.1750-3841.2008.00966.x.

    PMID: 19021816BACKGROUND

MeSH Terms

Conditions

Pouchitis

Condition Hierarchy (Ancestors)

IleitisEnteritisGastroenteritisGastrointestinal DiseasesDigestive System DiseasesIntestinal DiseasesIleal Diseases

Study Officials

  • Carl Brown

    Saint Paul's Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Head, Division of General Surgery, clinical assistant professor of surgery at University of British Columbia

Study Record Dates

First Submitted

July 19, 2014

First Posted

July 25, 2014

Study Start

October 1, 2014

Primary Completion

November 1, 2015

Study Completion

November 1, 2015

Last Updated

April 26, 2017

Record last verified: 2017-04

Locations